Management of Hypertensive Gangliocapsular Hemorrhage with Midline Shift in Chronic Kidney Disease

Immediate Neurosurgical Evaluation and ICU Admission

All patients with intracerebral hemorrhage require intensive care unit monitoring due to frequent ICP elevations, blood pressure instability, potential need for intubation, and multiple medical complications 1
The presence of midline shift indicates significant mass effect requiring urgent neurosurgical assessment for potential surgical intervention 2
Establish continuous monitoring of neurological status (GCS, NIHSS), blood pressure, intracranial pressure if indicated, and hemodynamic parameters 3, 4
Care in a dedicated neuroscience intensive care unit is associated with lower mortality rates 3, 4

Target systolic blood pressure <140 mm Hg within 1 hour of presentation and maintain for 7 days to improve functional recovery, based on the INTERACT2 trial 3, 4
Early intensive BP lowering is safe and feasible, with surviving patients showing modestly better functional recovery 3, 4
Use locally available intravenous agents following established protocols 3, 4
Continuous intra-arterial BP monitoring should be considered when using intravenous vasoactive medications 3, 4
Avoid sodium nitroprusside, which increases ICP and causes cerebral vasodilation 5

Begin with simple, non-pharmacologic measures first, including elevating the head of bed to 30 degrees with neck in neutral midline position to improve jugular venous outflow 6, 7, 8, 1
Ensure patient is not hypovolemic before head elevation, as this can drop CPP 6, 7
Provide adequate analgesia and sedation (propofol, etomidate, or midazolam for sedation; morphine or alfentanil for analgesia) 6
Use short-acting sedatives if intubation required to allow frequent neurological assessments 1
Hypertonic saline is the preferred osmotic agent in patients with CKD, avoiding mannitol which can cause intravascular volume depletion, renal failure, and rebound intracranial hypertension 6, 7, 8, 1

Discontinue all nephrotoxic medications immediately, including NSAIDs, aminoglycosides, and contrast agents 1
Monitor renal function and electrolytes every 6 hours during acute phase 1
Avoid aggressive fluid overload, as volume overload worsens cerebral edema and elevated ICP 1
Use isotonic crystalloids for volume expansion; avoid starch-containing solutions which are nephrotoxic and worsen AKI 1

Maintain adequate intravascular volume before initiating vasopressors to ensure optimal CPP 5
Carefully titrate fluid intake to output to avoid hypovolemia while preventing volume overload 5
Use isotonic or hypertonic maintenance fluids; avoid hypotonic fluids which worsen cerebral edema 1, 5
Restrict free water to avoid hypo-osmolar fluid that may worsen cerebral edema 5, 9

Neurological assessments every 1-2 hours using standardized scales (GCS, NIHSS, modified Rankin Scale) 3, 4, 1
Continuous cardiopulmonary monitoring including automated BP cuff, ECG telemetry, and pulse oximetry 3, 4
Monitor electrolytes, renal function, and serum osmolality every 6 hours during osmotic therapy 1
Monitor blood pressure and CPP continuously, and fluid balance strictly 1
Frequent vital sign checks to detect early deterioration 3, 4

Temperature control: Aggressively treat fever to normal levels, as fever worsens intracranial hypertension and is an independent prognostic factor 1
Seizure prophylaxis: Clinical seizures occur in up to 16% of ICH patients, with cortical involvement being the most important risk factor 4
Stress ulcer prophylaxis: Administer proton pump inhibitors or H2-receptor antagonists, as ICH patients have multiple risk factors for GI bleeding 1
Coagulopathy management: Do not routinely correct coagulopathy with fresh frozen plasma in the absence of active bleeding, as FFP can lead to volume overload that exacerbates intracranial hypertension 1

Do not use mannitol without careful consideration of renal function and volume status; hypertonic saline is safer in CKD 1
Avoid starch-containing fluids entirely, as they worsen AKI and increase mortality 1
Do not aggressively fluid resuscitate without considering ICP effects; balance renal perfusion needs with cerebral edema risk 1
Avoid hypotonic fluids which worsen cerebral edema 1, 5, 9
Do not use antihypertensive agents that cause cerebral vasodilation (e.g., sodium nitroprusside) 5